Executive Medical Director - Physician -early Clinical Development, Immunology

Eli Lilly Eli Lilly · Pharma · Boston, MA +2

Executive Medical Director role in Early Clinical Development for the Immunology team at Eli Lilly, focusing on developing transformational medicines for autoimmune and inflammatory diseases. The role involves strategic leadership, designing and executing early clinical studies, integrating translational endpoints, and collaborating with cross-functional teams, regulatory affairs, and external experts. Requires a physician scientist with strong clinical translational experience and leadership skills.

What you'd actually do

  1. Collaborate with discovery, translational medicine, and clinical teams to develop and refine therapeutic hypotheses for autoimmune and inflammatory diseases
  2. In collaboration with stakeholders, design early clinical studies that efficiently test therapeutic hypotheses
  3. Lead early clinical strategy in cross-functional teams through matrix influence, aligning diverse stakeholders around common objectives
  4. Establish and maintain relationships with key opinion leaders and scientific experts in autoimmunity and inflammation
  5. Partner with regulatory colleagues on IND strategy, FDA interactions, and global development planning

Skills

Required

  • Medical Doctor or Doctor of Osteopathy
  • Clinical translational experience
  • Experience in autoimmune and inflammatory diseases
  • Experience in early clinical development
  • Matrix leadership skills
  • Executive presence
  • Ability to inspire high-performing teams
  • Cross-functional collaboration
  • Scientific rigor
  • Clinical feasibility assessment
  • Regulatory affairs knowledge (IND submissions, FDA interactions)
  • GCP, FDA, ICH guidelines compliance
  • Experimental medicine approaches
  • Scientific exchange and communication
  • Relationship building with KOLs

Nice to have

  • Director/Sr Director level industry experience
  • Experience in target and modality selection
  • Experience evaluating external opportunities (partnerships/acquisitions)
  • Experience with biostatistics and clinical pharmacology
  • Experience with risk management planning
  • Experience with data analysis, scientific publications, and medical communications

What the JD emphasized

  • clinical translational leader
  • enterprise influence
  • transformational medicines
  • autoimmune and inflammatory diseases
  • therapeutic hypotheses
  • early clinical development
  • early clinical studies
  • translational endpoints
  • biomarker strategies
  • first-in-human
  • proof-of-concept
  • scientific expertise
  • key opinion leaders
  • scientific conferences
  • regulatory submissions
  • safety signal evaluation
  • scientific publications
  • medical communications